monocrotaline has been researched along with Disease, Pulmonary in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Kabwe, JC; Kawai, M; Maruyama, J; Maruyama, K; Okada, A; Sawada, H; Zhang, E | 1 |
| He, Y; Lian, W; Lin, G; Song, Z; Zhang, C | 1 |
| Haight, D; Lachant, DJ; Lyons, JA; Meoli, DF; Swarthout, RF; White, RJ | 1 |
| Barros, SS; Borges, AS; Colegate, SM; Maia, LA; Medeiros, RM; Pessoa, AF; Pessoa, CR; Riet-Correa, F; Soares, MP | 1 |
| Han, DD; Liu, M; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
| Brendel, K; Duhamel, RC; Huxtable, RJ; Lafranconi, WM | 1 |
| Hilliker, KS; Roth, RA | 1 |
| Furukawa, F; Hashimoto, K; Hayashi, Y; Kokubo, T; Otsuka, H; Takahashi, M | 1 |
| Campen, MJ; Costa, DL; Gardner, SY; Jackson, MC; Kodavanti, UP; Ledbetter, AD; Richards, JR; Watkinson, WP | 1 |
| Baybutt, RC; Molteni, A | 1 |
| Chakrabarti, S; Chen, L; Feng, Q; Gan, XT; Haist, JV; Karmazyn, M; Lu, X | 1 |
| Estep, JE; Lamé, MW; Morin, D; Pan, LC; Segall, HJ; Wilson, DW | 1 |
| Hayashi, K; Ito, K; Murakami, T; Nakashima, T | 1 |
| Gebb, SA; Gillespie, MN; Olson, JW; Orlinska, U | 1 |
| Buckpitt, AR; McLemore, TL; Roth, RA; Yost, GS | 1 |
| Hubbard, AK; Huxtable, RJ; Shubat, PJ | 1 |
| Hinz, JM; Molteni, A; Ts'ao, CH; Ward, WF | 1 |
| Fink, GD; Ganey, PE; Roth, RA | 1 |
| Bruner, LH; Carpenter, LJ; Hamlow, P; Roth, RA | 1 |
| Fasules, JW; Henson, PM; Reeves, JT; Stenmark, KR; Voelkel, NF | 1 |
| Ito, K; Murakami, K; Murakami, T; Nakashima, T | 1 |
2 review(s) available for monocrotaline and Disease, Pulmonary
| Article | Year |
|---|---|
Mechanisms and pathology of monocrotaline pulmonary toxicity.
Topics: Animals; Humans; Lung Diseases; Monocrotaline | 1992 |
Mechanisms of lung injury by systemically administered chemicals.
Topics: Animals; Biotransformation; Cricetinae; Indoles; Lung Diseases; Mice; Monocrotaline; Naphthalenes; Pyrrolizidine Alkaloids; Rats; Skatole; Terpenes | 1989 |
19 other study(ies) available for monocrotaline and Disease, Pulmonary
| Article | Year |
|---|---|
Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
Topics: Animals; Hypertension, Pulmonary; Lung Diseases; Male; Monocrotaline; Random Allocation; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Tidal Volume | 2022 |
Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids.
Topics: Animals; Erythrocytes; Hemoglobins; Hypoxia; Liver; Lung Diseases; Lung Injury; Monocrotaline; Oxygen; Pyrrolizidine Alkaloids; Rats | 2023 |
Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.
Topics: Acute Lung Injury; Animals; Apoptosis; Endothelial Cells; Female; Hypertension, Pulmonary; Lung; Lung Diseases; Male; Monocrotaline; Pneumonectomy; Pulmonary Artery; Rats | 2018 |
Pulmonary and hepatic lesions caused by the dehydropyrrolizidine alkaloid-producing plants Crotalaria juncea and Crotalaria retusa in donkeys.
Topics: Animals; Cell Proliferation; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Crotalaria; Equidae; Fibrosis; Liver; Lung; Lung Diseases; Monocrotaline; Plant Poisoning; Pyrrolizidine Alkaloids; Seeds | 2013 |
Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling.
Topics: Animals; Dose-Response Relationship, Drug; Down-Regulation; Fluoxetine; Inflammation; Lung; Lung Diseases; Monocrotaline; Osteopontin; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Inbred WF; Selective Serotonin Reuptake Inhibitors | 2011 |
Differentiation of the cardiac and pulmonary toxicity of monocrotaline, a pyrrolizidine alkaloid.
Topics: Animals; Cardiomegaly; Collagen; DNA; Female; Hydroxyproline; Lipid Metabolism; Lung Diseases; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; RNA | 1984 |
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogenase; Lung; Lung Diseases; Monocrotaline; Myocardium; Organ Size; Pyrrolizidine Alkaloids; Rats; Sulfinpyrazone | 1984 |
Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Endothelium; Lung Diseases; Male; Monocrotaline; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1984 |
Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
Topics: Administration, Inhalation; Air Pollutants; Animals; Bronchoalveolar Lavage Fluid; Carbon; Coal Ash; Cytokines; Disease Models, Animal; DNA, Complementary; Hypertension, Pulmonary; Intubation, Intratracheal; Lung; Lung Diseases; Male; Monocrotaline; Particulate Matter; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Survival Rate | 1999 |
Dietary beta-carotene protects lung and liver parenchyma of rats treated with monocrotaline.
Topics: Animals; Antidotes; Antioxidants; beta Carotene; Chemical and Drug Induced Liver Injury; Collagen; Diet; Fatty Liver; Hemorrhage; Hypertrophy, Right Ventricular; Liver; Lung; Lung Diseases; Male; Monocrotaline; Poisons; Rats; Rats, Sprague-Dawley | 1999 |
Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Cell Size; Enzyme Inhibitors; Guanidines; Heart Failure; Hemodynamics; Hypertrophy, Right Ventricular; Lung; Lung Diseases; Male; Monocrotaline; Myocardium; Organ Size; Poisons; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Hydrogen Exchangers; Sulfones | 2001 |
Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Autacoids; Blood Pressure; Body Weight; Bradykinin; Dinoprostone; Injections, Subcutaneous; Lung; Lung Diseases; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Substance P; Time Factors | 1988 |
Acetylated polyamines in lungs from rats with monocrotaline-induced pneumotoxicity.
Topics: Acetylation; Acetyltransferases; Animals; Biogenic Polyamines; Cytosol; Dose-Response Relationship, Drug; Lung; Lung Diseases; Male; Monocrotaline; Putrescine; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Spermidine; Spermine; Time Factors | 1989 |
Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
Topics: Administration, Oral; Animals; Bronchoalveolar Lavage Fluid; Cardiomegaly; Dose-Response Relationship, Drug; Drug Interactions; Lung Diseases; Male; Monocrotaline; Organ Size; Phenobarbital; Pulmonary Artery; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1989 |
Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
Topics: Animals; Cardiomegaly; Chlorobenzoates; Epoprostenol; Hydroxyproline; Lung Diseases; Male; Monocrotaline; Organ Size; Pancreatic Elastase; Peptidyl-Dipeptidase A; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thromboxane A2; Tissue Plasminogen Activator | 1989 |
The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
Topics: Animals; Biotransformation; Body Weight; Cardiomegaly; Diet; Diet, Sodium-Restricted; L-Lactate Dehydrogenase; Lung Diseases; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Sodium | 1985 |
Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
Topics: Animals; Enzyme Induction; Heart; Lung Diseases; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mixed Function Oxygenases; Monocrotaline; Pharmaceutical Vehicles; Phenobarbital; Proadifen; Pyrrolizidine Alkaloids; Rats; Structure-Activity Relationship | 1986 |
Neither anticoagulant nor nonanticoagulant heparin affects monocrotaline lung injury.
Topics: Animals; Anticoagulants; Arteries; Blood Pressure; Capillary Permeability; Heparin; Lung; Lung Diseases; Male; Monocrotaline; Partial Thromboplastin Time; Pulmonary Circulation; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; SRS-A; Thrombin Time | 1987 |
Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Dinoprost; Endothelium, Vascular; In Vitro Techniques; Lung; Lung Diseases; Male; Monocrotaline; Muscle Relaxation; Potassium Chloride; Pulmonary Artery; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1988 |